Literature DB >> 36085499

HSV-1's contribution as a vector for gene therapy.

Alberto L Epstein1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 36085499     DOI： 10.1038/s41587-022-01449-1

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   68.164


× No keyword cloud information.
  2 in total

Review 1.  Repression of viral transcription during herpes simplex virus latency.

Authors:  C M Preston
Journal:  J Gen Virol       Date:  2000-01       Impact factor: 3.891

2.  Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicity.

Authors:  Yoshitaka Miyagawa; Pietro Marino; Gianluca Verlengia; Hiroaki Uchida; William F Goins; Shinichiro Yokota; David A Geller; Osamu Yoshida; Joseph Mester; Justus B Cohen; Joseph C Glorioso
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-16       Impact factor: 11.205
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.